Management of tricyclic antidepressant toxicities.
D000929:Antidepressive Agents, Tricyclic / Q000378:metabolism / Q000633:toxicity*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000628:therapy; D002606:Charcoal / Q000627:therapeutic use; D003128:Coma / Q000139:chemically induced; D004639:Emetics / Q000627:therapeutic use; D005751:Gastric Lavage; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007022:Hypotension / Q000628:therapy; D008099:Liver / Q000378:metabolism; D010830:Physostigmine / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced; D013997:Time Factors; D014882:Water-Electrolyte Balance
D000929:Antidepressive Agents, Tricyclic; D004639:Emetics; D002606:Charcoal; D010830:Physostigmine